Journal of the American Chemical Society
COMMUNICATION
the heterodinuclear rare earth metal Schiff base catalysts are
ongoing.
J. Am. Chem. Soc. 2007, 129, 8103. Thiols:(c) Della Sala, G.; Lattanzi, A.
Org. Lett. 2009, 11, 3330. (d) Larson, S. E.; Baso, J. C.; Li., G.; Antilla,
J. C. Org. Lett. 2009, 11, 5186. See also a review in ref 6.
(10) For examples using Brønsted basic rare earth metal alkoxide in
combination with transition metals, see: Cu/Sm(O-iPr)3 cat:(a) Handa,
S.; Gnanadesikan, V.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc.
2007, 129, 4900. (b) Handa, S.; Gnanadesikan, V.; Matsunaga, S.;
Shibasaki, M. J. Am. Chem. Soc. 2010, 132, 4925. Pd/La(O-iPr)3 cat:
(c) Handa, S.; Nagawa, K.; Sohtome, Y.; Matsunaga, S.; Shibasaki, M.
Angew. Chem., Int. Ed 2008, 47, 3230. Ni/La(O-iPr)3 cat:(d) Furutachi,
M.; Mouri, S.; Matsunaga, S.; Shibasaki, M. Chem. Asian J. 2010, 5, 2351.
(11) For an example using Lewis acidic rare earth metal triflate in
combination with a group 13 metal alkoxide, see: Ga(OiPr)3/Yb-
(OTf)3 cat:Mihara, H.; Xu, Y.; Shepherd, N. E.; Matsunaga, S.;
Shibasaki, M. J. Am. Chem. Soc. 2009, 131, 8384.
(12) For selected examples of bifunctional heterobimetallic Schiff
base complexes in asymmetric catalysis, see:(a) Annamalai, V.; DiMauro,
E. F.; Carroll, P. J.; Kozlowski, M. C. J. Org. Chem. 2003, 68, 1973 and
references therein. (b) Yang, M.; Zhu, C.; Yuan, F.; Huang, Y.; Pan, Y. Org.
Lett. 2005, 7, 1927. (c) Li, W.; Thakur, S. S.; Chen, S.-W; Shin, C.-K.;
Kawthekar, R. B.; Kim, G.-J. Tetrahedron Lett. 2006, 47, 3453. For related
homobimetallic Schiff base catalysts, see:(d) Hirahata, W.; Thomas, R. M.;
Lobkovsky, E. B.; Coates, G. W. J. Am. Chem. Soc. 2008, 130, 17658.
(e) Mazet, C.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2008, 47, 1762.
(f) Wu, B.; Parquette, J. R.; RajanBabu, T. V. Science 2009, 326, 1662.
(13) For the X-ray crystallographic structure of related heterobime-
tallic complex having cationic rare earth metal in the outer O2O2
cavity, see:(a) Koner, R.; Lee, G.-H.; Wang, Y.; Wei, H.-H.; Mohanta,
S. Eur. J. Inorg. Chem. 2005, 1500. For the utility of methoxy-substituted
Schiff base 1 in metal/1 = 1:1 ratio system, see:(b) Yoshino, T.;
Morimoto, H.; Lu, G.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc.
2009, 131, 17082. (c) Mouri, S.; Chen, Z.; Mitsunuma, H.; Furutachi,
M.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc. 2010, 132, 1255. See
also works by RajanBabu et al. in refs 8c and 12f.
’ ASSOCIATED CONTENT
S
Supporting Information. Experimental procedures, de-
b
termination of relative and absolute configuration by X-ray
crystallographic analysis (CIF), and spectral data of new com-
pounds. This material is available free of charge via the Internet at
’ AUTHOR INFORMATION
Corresponding Author
smatsuna@mol.f.u-tokyo.ac.jp; mshibasa@bikaken.or.jp
’ ACKNOWLEDGMENT
This work was supported by Grant-in-aid for Young Scientist
(A) from JSPS, Takeda Science foundation, and Inoue Science
Research Award from Inoue Science Foundation (for S.M.). Y.X.
thanks JSPS predoctoral research fellowship and L.L. thanks
Uehera Memorial Foundation for scholarship.
’ REFERENCES
(1) (a) Bryans, J. S.; Wustrow, D. J. Med. Res. Rev. 1999, 19, 149.(b)
Cooper, J. R.; Bloom, F. E.; Roth, R. H. The Biochemical Basis of
Neuropharmacology; Oxford Press: Oxford, 2003. (c) Tassone, D. M.;
Boyce, E.; Guyer, J.; Nuzum, D. Clin. Ther. 2007, 29, 26.
(2) Reviews on the foldamer research:(a) Goodman, C. M.; Choi, S.;
Shandler, S.; Degrado, W. F. Nat. Chem. Biol. 2007, 3, 252. (b) Seebach,
D.; Brenner, M.; Rueping, M.; Jaun, B. Chem.ÀEur. J. 2002, 8, 573.
(c) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173.
(3) (a) Nodes, W. J.; Nutt, D. R.; Chippindale, A. M.; Cobb, A. J. A.
J. Am. Chem. Soc. 2009, 131, 16016. (b) Guo, L.; Chi, Y.; Almeida, A. M.;
Guzei, I. A.; Parker, B. K.; Gellman, S. H. J. Am. Chem. Soc. 2009,
131, 16018. For an alternative approach via asymmetric conjugate
addition of malonates to 3-nitro-2H-chromenes, see:(c) Chen, W.-Y.;
Ouyang, L.; Chen, R.-Y.; Li, X.-S. Tetrahedron Lett. 2010, 51, 3972.
(4) (a) Smith, P. W.; Whittington, A. R.; Cobley, K. N.; Jaxa-Chamiec, A.;
Finch, H. J. Chem. Soc., Perkin Trans. 1 2001, 21. (b) Blyumin, E. V.; Gallon,
H. J.; Yudin, A. K. Org. Lett. 2007, 9, 4677. (c) Page, M. F. Z.; Jalisatgi, S. S.;
Maderna, A.; Hawthorne, M. F. Synthesis 2008, 550.
(14) Evaluation of the relative Lewis acidity of rare earth metals:
Tsuruta, H.; Yamaguchi, K.; Imamoto, T. Chem. Commun 1999, 1703The
reactivity changed in correlation with Lewis acidity of rare earth metal
triflate (Yb, Y > Gd > Sm > La).
(15) Rearrangement of aziridine 2a to 2-aryloxazoline predomi-
nantly proceeded in the absence of La(O-iPr)3. For Lewis acid-pro-
moted rearrangement of N-acylaziridines into oxazolines, seeFerraris,
D.; Drury, W. J., III; Cox, C.; Lectka, T. J. Org. Chem. 1998, 63, 4568.
(16) The addition of catalytic amount of amine base was effective to
suppress the undesired Lewis acid-promoted intramolecular rearrange-
ment of aziridines 2 to 2-aryloxazolines, and to promote the desired
intermolecular reaction of malonate 3a with aziridines 2.
(17) The reactions were run using 10 mol % catalyst loading in
entries 7À13, because the reactivity of aziridines 2bÀ2h was lower than
that of aziridine 2a.
(5) Catalytic enantioselective alkylation of β-keto esters with un-
substituted aziridines has been reported, see:(a) Moss, T. A.; Fenwick,
D. R.; Dixon, D. J. J. Am. Chem. Soc. 2008, 130, 10076. (b) Paix~ao, M. W.;
Nielsen, M.; Jacobsen, C. B.; Jørgensen, K. A. Org. Biomol. Chem. 2008,
6, 3467.
(6) A review:Schneider, C. Angew. Chem., Int. Ed. 2009, 48, 2082.
(7) Aziridine ring-opening desymmetrization with azide:(a) Li, Z.;
Fernandez, M.; Jacobsen, E. N. Org. Lett. 1999, 1, 1611. (b) Fukuta, Y.;
Mita, T.; Fukuda, N.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2006,
128, 6312. (c) Rowland, E. B.; Rowland, G. B.; Rivera-Otero, E.; Antilla,
J. C. J. Am. Chem. Soc. 2007, 129, 12084. (d) Nakamura, S.; Hayashi, M.;
Kamada, Y.; Sasaki, R.; Hiramatsu, Y.; Shibata, N.; Toru, T. Tetrahedron
Lett. 2010, 51, 3820. See also ref 8c.
(8) Aziridine ring-opening desymmetrization with cyanide:(a) Mita,
T.; Fujimori, I.; Wada, R.; Wen, J.; Kanai, M.; Shibasaki, M. J. Am. Chem.
Soc. 2005, 127, 11252. (b) Fujimori, I.; Mita, T.; Maki, K.; Shiro, M.;
Sato, A.; Furusho, S.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2006,
128, 16438. (c) Wu, B.; Gallucci, J. C.; Parquette, J. R.; RajanBabu, T. V.
Angew. Chem., Int. Ed. 2009, 48, 1126.
(9) Aziridine ring-opening with other nucleophiles, see Grignard
reagent:(a) M€uller, P.; Nury, P. Org. Lett. 1999, 1, 439. Anilines:(b) Arai,
K.; Lucarini, S.; Salter, M. M.; Ohta, K.; Yamashita, Y.; Kobayashi, S.
5793
dx.doi.org/10.1021/ja201492x |J. Am. Chem. Soc. 2011, 133, 5791–5793